Exportin-T (XPOT) belongs to the RAN-GTPase exportin family that mediates export of tRNA from the nucleus to the cytoplasm. Up-regulation of XPOT indicates poor prognosis in breast cancer patients. However, the correlation between XPOT and hepatocellular carcinoma (HCC) remains unclear. Here, we found that high expression of XPOT in HCC indicated worse prognosis via bioinformatics analysis. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
| INTRODUCTION
Hepatocellular carcinoma (HCC) is the one of the leading causes of cancer death worldwide. 1 The incidence of HCC is increasing due to the prevalence of obesity and diabetes mellitus. 2 A high frequency of tumor recurrence and metastasis leads to poor prognosis. 3, 4 Although some progress has been made in the study of HCC in recent years, [5] [6] [7] existing therapeutic methods have limited effects on advanced HCC patients. The underlying mechanism of HCC remains unclear.
Therefore, further exploration of the mechanism of HCC progression will contribute to the development of new therapeutic targets.
Exportin-T (XPOT) is a member of the importin (karyopherin) β family,
which is characterized as a nuclear export receptor for tRNAs. 8 XPOT can translocate tRNAs from the nucleus to the cytoplasm by forming a ternary transport complex with Ran-GTP and newly synthesized tRNAs. 9 XPOT plays a prominent role in coordination between the protein translation and the nuclear tRNA processing and transport machineries. 10 Previous studies have shown that XPOT can promote tumor progression in various cancers. XPOT was found to be up-regulated in malignant pleural mesothelioma. 11 Elevated XPOT contributes to chromosome instability and worsen breast cancer patient prognosis. 12 Decreased expression of XPOT was related to inhibition of cell proliferation in human promyelocytic leukemia HL-60 cells. 13 However, whether XPOT functions in tumor progression has still not been studied. Here, we found elevated expression of XPOT in HCC and further explored the role of XPOT in tumor proliferation and invasion for the first time.
In our study, we found that XPOT was significantly up-regulated in TCGA datasets, GEO (GSE6764, GSE14520, GSE36376, GSE45436, and GSE62232) and HCC patients, indicating poor prognosis. Downregulation of XPOT inhibited tumor proliferation and invasion in vitro and vivo. Gene sets enrichment analysis (GSEA) results indicated that XPOT was closely related to cell cycle and ubiquitin-mediated proteolysis. Mechanistically, knockdown of XPOT significantly decreased the expression of cyclin-dependent kinase 1 (CDK1), cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 2 (CDK4), CyclinA1 (CCNA1), CyclinB1 (CCNB1), CyclinB2 (CCNB2), 
| High-throughput data processing
The expression data for HCC were obtained from TCGA (http//gdc.
cancer.gov/) and GEO GSE6764, GSE14520, GSE36376, GSE45436
and GSE62232 (http://www.ncbi.nlm.nih.gov/geo). All data were log2
transformed, and the results were analyzed using edgeR and GraphPad Prism 7 software. The edgeR package that we used was based on negative binomial distributions, empirical Bayes estimation, exact tests, generalized linear models (GLM) and quasi-likelihood tests. A logFC (fold change) ≥1.0 or logFC ≤−1.0 associated with a P < 0.05 was selected as statistically significant for the genes.
| Immunohistochemical staining and antibodies
Tissue specimens from 95 cases of HCC fixed in formalin and embedded in paraffin were used for XPOT immunohistochemistry. XPOT antibodies for immunohistochemistry staining were obtained from Bioss (bs-14673R).
After deparaffinization, hydration and blocking, the specimens were mixed with primary anti-XPOT goat polyclonal antibody and then incubated overnight at 4°C (dilution ratio 1:1000). as follows:
Positive cells were identified by puromycin screening.
| Western blot and antibodies
The 
| Cell proliferation assay
Cell Counting Kit-8 (CCK8, Dojindo, Tabaru, Japan) was used to measure cell proliferation. The cells were seeded into 96-well plates.
The absorption values were measured at following time points: 24, 48, 72, and 96 h after siRNA transfection. The assays were repeated three times, and the data are shown as the mean ± SD.
| Flow cytometry
For the cell cycle analysis, HCC cells were harvested, fixed in 75% ethanol and stored at 4°C overnight. Then, the cells were stained with DNA Prep (Beckman Coulter, Brea, CA), and flow cytometry was performed to detect the percentage of cells in different phases according to their DNA content.
| Scratch wound healing assay
HCC transfected cells were seeded into 6-well plates and then were incubated at 37°C with 5% CO 2 until they reached 100% confluence.
Then, a 10-μL pipette was used to scratch the monolayer. After cell fragments were washed away, the cells were cultured under normal conditions. Photograph were taken at 0 and 24 h. The data are shown as the relative distance between two edges.
| Cell invasion assay
Cell invasion was assessed by Transwell chambers. Transwell assays were performed using polyethylene terephthalate-based migration chambers FIGURE 1 XPOT is upregulated in HCC tissues compared with ANLTs. XPOT was highly expressed in HCC tissues compared with normal liver tissues according to analysis of data from TCGA (A; tumor, n = 369; normal = 50, *P < 0.01) and GEO (B-F; GSE14520, tumor, n = 225; normal, n = 220, ****P < 0.0001; GSE45436, tumor, n = 95; normal, n = 39, ****P < 0.0001; GSE62232, tumor, n = 81; normal, n = 10, ****P < 0.0001; GSE6764, tumor, n = 35; normal, n = 23, ****P < 0.0001; GSE36376, tumor, n = 240; normal, n = 193, ****P < 0.0001). (H) Real-time PCR analysis of XPOT expression in 16 pairs of HCC specimens and corresponding ANLTs (***P = 0.0003). All *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
[Color figure can be viewed at wileyonlinelibrary.com]
and BD BioCoat Matrigel Invasion Chambers (Becton Dickinson Labware).
Cells in serum-free media were distributed into the inserts. Equal amounts of growth media were placed into the wells. After overnight culture, the chamber membrane was stained with 50% methanol blue/ethanol overnight. The data are shown as the mean ± SD.
| Animal experiments
Animal experiments were performed according to the protocol filed 
| Overexpression of XPOT predicts poor survival in patients with HCC
To determine the prognostic value of XPOT, we performed Kaplan-Meier analysis, and the results are shown in Figure 2 .
Overexpression of XPOT indicated inferior OS and DFS. Then, we used a Cox proportional hazard model to examine whether XPOT can serve as independent prognostic factor in 95 HCC patients in our center. The results indicated that the patients with high XPOT expression level had a poor prognosis (Figure 2 ). The multivariate analysis demonstrated that XPOT expression (HR 2.39, 95%CI
1.02-6.22, P < 0.05) was an independent prognostic factor for OS (Table 2 ). XPOT can serve as an independent prognostic biomarker for HCC patients.
| Altered XPOT expression affects cell proliferation
We examined the expression of XPOT in 5 HCC cell lines and found the higher expression of XPOT in HepG2 and SMMC-7721
( Figure 3B) . To investigate the function of XPOT in HCC, we transfected the HepG2 and SMMC-7721 cell lines with three siRNAs (si-1, si-2, and si-3) targeting XPOT and control siRNA.
Western blot analyses indicated that the expression of XPOT was significantly decreased in XPOT-siRNA-transfected cells compared with that of the control groups ( Figure 3A) . The CCK8 assay results indicated that downregulation of XPOT in both HepG2 and 7721 cell lines inhibited cell proliferation compared with that of the control groups at 24 h after transfection (P < 0.05; Figures 3C and   3D ).
| Down-regulation of XPOT decreases HCC cell motility
Scratch wound healing assays and invasion assays were performed to detect the effect of XPOT on cell motility. The XPOT-siRNA groups showed a lower migratory capacity than the control groups (P < 0.05).
In the invasion assay, downregulation of XPOT significantly decreased the invasive abilities of both SMMC-7721 cells (P < 0.05) and HepG2 cells (P < 0.05; Figures 3E-G) . XPOT-siRNA cells closed the scratch wounds more slowly than control cells at 24 h in the HepG2 (P < 0.05) and 7721 (P < 0.05) cell lines ( Figure 4 ). These data suggest that XPOT plays a critical role in the motility of HCC cells. Figures 5B-E) . The mice were euthanized, and tumors were measured 28 days after the cell injection. The tumor weight at the end of the experiment was markedly lower in the shXPOT-transfected HepG2 group (P < 0.0001; Figure 5D ). Moreover, IHC staining showed that proliferation marker gene Ki-67 was dramatically downregulated in XPOT knockdown tumors ( Figures 5H and 5I ). These findings indicated that the knockdown of XPOT inhibits tumorigenesis in vivo.
| GSEA
GSEA was conducted to investigate the mechanism of XPOT orchestrating tumor cell proliferation and invasion in 3.7 | XPOT promoted HCC progression by up-regulating cyclins and CDKs Relative density of cyclins and CDKs in sh2-XPOT and control groups (CDK1, **P = 0.0019; CDK2, ****P < 0.0001; CDK4, ****P < 0.0001; CCNA1, ***P = 0.0008; CCNB1, ***P = 0.0006; CCNB2, ****P < 0.0001; CCNE2, **P = 0.0018). All *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. [Color figure can be viewed at wileyonlinelibrary.com] CDK1, CDK2, CDK4, CCNA1, CCNB1, CCNB2 and CCNE2 were lower in sh2-XPOT treated cells ( Figure 7B ).
| DISCUSSION
In the present study, we found significant upregulation of XPOT in XPOT is a Ran-GTP-dependent tRNA receptor orchestrating translocation of tRNA from the nucleus to the cytoplasm in human cells. 15, 16 XPOT binds to mature tRNAs directly by recognizing the base of the acceptor arm, the TΨC loop and correctly matured 5′ and 3′ ends. 15, 17, 18 The regulation of gene expression relies in part on the controlled exchange of XPOT. Emerging evidence has linked Importin β-like nuclear export receptors to several types of diseases, including cancers. 19, 20 Elevated expression of XPOT is associated with cell proliferation in human promyelocytic leukemia. 13 Overexpression of XPOT leads to more aggressive and chromosomally unstable breast cancers. 12 However, the role of XPOT in HCC has not been studied before. We demonstrated that XPOT promotes cell proliferation and invasion in HCC for the first time. In conclusion, we demonstrated that XPOT promotes tumor proliferation and invasion in HCC. Our results indicated that XPOT may affect the tumor cell cycle through ubiquitin-mediated proteolysis.
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